Guardant Health, Inc. is 3.6x more valuable than Caris Life Sciences, Inc. by market capitalization ($17.33 B vs $4.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CAI | GH |
|---|---|---|
| Market cap | $4.85 B | $17.33 B |
| US-listed rank | #1404 | #671 |
| Revenue (latest FY) | $812.03M | $982.02M |
| Net income (latest FY) | -$68.09M | -$416.30M |
| Net margin | -8.4% | -42.4% |
| SEC filings | 102 | 1,131 |
Guardant Health, Inc. is 3.6x more valuable than Caris Life Sciences, Inc. by market capitalization ($17.33 B vs $4.85 B).
In their latest fiscal years, Caris Life Sciences, Inc. reported $812.03M in revenue while Guardant Health, Inc. reported $982.02M.
Full pages: Caris Life Sciences, Inc. and Guardant Health, Inc., or browse the full rankings.